A case of atypical heart failure

Česká verzia

Authors: J. Brotánek
Authors place of work: II. interní klinika, Fakultní Thomayerova nemocnice, Praha
Published in the journal: Kardiol Rev Int Med 2011, 13(2): 121-122
Category: Case Report

Summary

We present a case of a male patient with chronic heart failure with underlying ischemic heart disease complicated by intracardiac thrombosis. We show a positive effect of reduced heart rate on angina and chronic heart failure.

Keywords:
IHD – chronic heart failure – heart rate – ivabradine

Zdroje

1. Špinar J, Hradec J, Meluzin J et al. Doporučení pro diagnostiku a léčbu chronického srdečního selhání ČKS 2006. Cor et Vasa 2007; 49: Kardio: K5–K34.

2. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933–989.

3. Hradec J. Ivabradin v léčbě pacientů s chronickým srdečním selháním a vliv srdeční frekvence – studie SHIFT. Farmakoterapie 2011; 7: 28–31.

4. Fox K, Ford I, Steg PG et al. BEAUTIFUL Investigators. Ivabradine for patiens with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo controlled trial. Lancet 2008; 372: 807–816.

5. Swedberg K, Komajda M, Böhm M et al. SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomisedplacebo-controlled study. Lancet 2010; 376: 875–885.

6. Vítovec J, Špinar J. Studie SHIFT (The Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial) a její význam pro léčbu srdečního selhání. Kardiol Rev 2010; 12: 125–127.

7. Vítovec J, Špinar J. Snížení srdeční frekvence u srdečního selhání – studie SHIFT. Postgrad Med 2011; 13: 140–143.